Immunopathogenesis of Rheumatoid Arthritis.

Immunity 2017 02;46(2):183-196

Institute of Infection Immunity and Inflammation, University of Glasgow, Glasgow G128QQ, UK. Electronic address:

Rheumatoid arthritis (RA) is the most common inflammatory arthropathy. The majority of evidence, derived from genetics, tissue analyses, models, and clinical studies, points to an immune-mediated etiology associated with stromal tissue dysregulation that together propogate chronic inflammation and articular destruction. A pre-RA phase lasting months to years may be characterized by the presence of circulating autoantibodies, increasing concentration and range of inflammatory cytokines and chemokines, and altered metabolism. Clinical disease onset comprises synovitis and systemic comorbidities affecting the vasculature, metabolism, and bone. Targeted immune therapeutics and aggressive treatment strategies have substantially improved clinical outcomes and informed pathogenetic understanding, but no cure as yet exists. Herein we review recent data that support intriguing models of disease pathogenesis. They allude to the possibility of restoration of immunologic homeostasis and thus a state of tolerance associated with drug-free remission. This target represents a bold vision for the future of RA therapeutics.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.immuni.2017.02.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385708PMC
February 2017
12 Reads

Publication Analysis

Top Keywords

rheumatoid arthritis
8
vasculature metabolism
4
metabolism bone
4
comorbidities vasculature
4
systemic comorbidities
4
synovitis systemic
4
bone targeted
4
comprises synovitis
4
targeted immune
4
treatment strategies
4
strategies improved
4
aggressive treatment
4
therapeutics aggressive
4
immune therapeutics
4
onset comprises
4
clinical disease
4
autoantibodies increasing
4
increasing concentration
4
circulating autoantibodies
4
presence circulating
4

Similar Publications